Anti-angiogenic Therapy for Retinal Disease. - sprookjes - yvandenbroek - TriplyDB

Anti-angiogenic Therapy for Retinal Disease.

Anti-angiogenic Therapy for Retinal Disease.

http://www.wikidata.org/entity/Q38805247

about

Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

P2860

Q55275094-B3F80075-B414-4F83-AD17-60E68DC646AC

P2860

Anti-angiogenic Therapy for Retinal Disease.

http://www.wikidata.org/entity/Q38805247

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Anti-angiogenic Therapy for Retinal Disease.

@en

type

label

Anti-angiogenic Therapy for Retinal Disease.

@en

prefLabel

Anti-angiogenic Therapy for Retinal Disease.

@en

P1433

Q38805247-6EB154A0-2F1E-44A3-B1A0-87330331961F

P1476

Q38805247-3A1ED1F8-A64E-4534-BFE9-07C4A54650D7

P2093

Q38805247-054E5BD1-6CFA-4690-8617-C2341B203544

Q38805247-EFCA8BB4-76F1-4B5E-ABD1-CB4D9DFC4A0E

P2860

Q38805247-011F85C0-EAAC-494C-8C97-861C2891495E

Q38805247-0134E43C-CAB9-4552-A4D1-607A33B38B93

Q38805247-04319B1B-F70A-461F-BAF4-ECC49D03BF1F

Q38805247-055259B2-A2EA-4BD5-85ED-7856A6FF36C9

Q38805247-05AFA79D-0D58-4811-BC6D-E70745C3030D

Q38805247-0A31D14B-E428-4A63-90FC-3DBF06A15E3E

Q38805247-0BAB48DE-03F8-46DB-8B9E-E939E88CEA74

Q38805247-0CA9F3E6-4738-45B4-B0A3-C1A3E2C61D74

Q38805247-0D1B1AB9-AB56-4BF5-86E4-704DAD339D85

Q38805247-0E813006-DB18-418A-BB5A-92A9F4366A65

P304

Q38805247-672F3250-FC92-49FA-A84D-FE705A2282CF

P31

Q38805247-9738A5E3-BBF8-419E-AE23-7126ED35949E

P356

Q38805247-29DA6DAF-D972-4A22-A3A1-D4EF5F6362A9

P478

Q38805247-585EB520-F39C-4500-852A-8609473DC0EC

P577

Q38805247-D9B3BF71-F336-46BE-9498-4F39C44D4D06

P698

Q38805247-EF410C18-74DB-47AE-8150-4A564F0780A0

P932

Q38805247-A0B276B4-25AC-440B-8C8F-7EEC9A268DE6

P356

P1433

Handbook of experimental pharmacology

P1476

Anti-angiogenic Therapy for Retinal Disease.

@en

P2093

Akrit Sodhi

http://www.w3.org/2001/XMLSchema#string

Yannis M Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

CCR3 is a target for age-related macular degeneration diagnosis and therapy

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

P304

271-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2016_78

http://www.w3.org/2001/XMLSchema#string

P478

242

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27783271

http://www.w3.org/2001/XMLSchema#string

P932

5451313

http://www.w3.org/2001/XMLSchema#string